Horizon Therapeutics Public Ltd Co

JANUS HENDERSON GROUP PLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

134,617

Value ($000)

15,572

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	15,572	0.0%	134,617	9/30/2023
2023 Q2	8/14/2023	10,501	0.0%	102,100	6/30/2023
2023 Q1	5/15/2023	189,727	0.1%	1,738,146	3/31/2023
2022 Q4	2/14/2023	449,447	0.3%	3,949,519	12/31/2022
2022 Q3	11/14/2022	373,632	0.3%	6,037,018	9/30/2022
2022 Q2	8/15/2022	593,181	0.4%	7,436,610	6/30/2022
2022 Q1	5/16/2022	754,114	0.4%	7,167,617	3/31/2022
2021 Q4	2/14/2022	759,951	0.3%	7,052,188	12/31/2021
2021 Q3	11/16/2021	663,123	0.3%	6,053,732	9/30/2021
2021 Q2	8/16/2021	545,382	0.2%	5,824,194	6/30/2021
2021 Q1	5/17/2021	699,243	0.3%	7,597,157	3/31/2021
2020 Q4	2/16/2021	599,294	0.3%	8,192,621	12/31/2020
2020 Q3	11/16/2020	694,317	0.4%	8,938,153	9/30/2020
2020 Q2	8/14/2020	464,509	0.3%	8,357,524	6/30/2020
2020 Q1	5/14/2020	197,948	0.1%	6,682,922	3/31/2020
2019 Q4	2/18/2020	212,697	0.1%	5,875,619	12/31/2019